Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Olencki

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Optimal treatment of unresectable nonmelanoma skin cancersThomas Olencki
Current Problems in Cancer|November 27, 2021
Survival benefit with resection of brain metastases from renal cell carcinoma in the setting of molecular targeted therapy and/or immune therapyKristin Huntoon, Mark Damante, Joshua Wang, et al.
Cureus|July 23, 2019
Successful Treatment and Five Years of Disease-free Survival in a Donor Transmitted Metastatic Melanoma with Ipilimumab TherapyPriyamvada Singh, Deepali Pandey, Brad Rovin, et al.
The Journal of Clinical and Aesthetic Dermatology|September 25, 2013
A Global Review of Melanoma Follow-up GuidelinesShannon C Trotter, Novie Sroa, Richard R Winkelmann, et al.
Neurosurgical Focus|August 1, 2023
Association between systemic treatment with immune checkpoint inhibitor therapy in renal cell carcinoma and reduced risk of brain metastasis developmentMark Damante, Kristin Huntoon, David Gibbs, et al.
Clinical Genitourinary Cancer|July 25, 2006
Adjuvant subcutaneous interleukin-2 in patients with resected renal cell carcinoma: a pilot studyNavneet S Majhail, Laura Wood, Paul Elson, et al.
Journal of the American Academy of Dermatology|January 15, 2018
Guidelines of care for the management of basal cell carcinoma, , John Y S Kim, et al.
Investigational New Drugs|May 10, 2006
Phase I trial of thalidomide and interleukin-2 in patients with metastatic renal cell carcinomaThomas Olencki, Sareena Malhi, Tarek Mekhail, et al.
The Open Ophthalmology Journal|July 17, 2012
Long-term survivors with metastatic uveal melanomaDominic M Buzzacco, Mohamed H Abdel-Rahman, Stanley Park, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 18, 2011
Gene regulatory and clinical effects of interferon β in patients with metastatic melanoma: a phase II trialErnest C Borden, Barbara Jacobs, Emese Hollovary, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Optimal treatment of unresectable nonmelanoma skin cancersThomas Olencki
Current Problems in Cancer|November 27, 2021
Survival benefit with resection of brain metastases from renal cell carcinoma in the setting of molecular targeted therapy and/or immune therapyKristin Huntoon, Mark Damante, Joshua Wang, et al.
Cureus|July 23, 2019
Successful Treatment and Five Years of Disease-free Survival in a Donor Transmitted Metastatic Melanoma with Ipilimumab TherapyPriyamvada Singh, Deepali Pandey, Brad Rovin, et al.
The Journal of Clinical and Aesthetic Dermatology|September 25, 2013
A Global Review of Melanoma Follow-up GuidelinesShannon C Trotter, Novie Sroa, Richard R Winkelmann, et al.
Neurosurgical Focus|August 1, 2023
Association between systemic treatment with immune checkpoint inhibitor therapy in renal cell carcinoma and reduced risk of brain metastasis developmentMark Damante, Kristin Huntoon, David Gibbs, et al.
Clinical Genitourinary Cancer|July 25, 2006
Adjuvant subcutaneous interleukin-2 in patients with resected renal cell carcinoma: a pilot studyNavneet S Majhail, Laura Wood, Paul Elson, et al.
Journal of the American Academy of Dermatology|January 15, 2018
Guidelines of care for the management of basal cell carcinoma, , John Y S Kim, et al.
Investigational New Drugs|May 10, 2006
Phase I trial of thalidomide and interleukin-2 in patients with metastatic renal cell carcinomaThomas Olencki, Sareena Malhi, Tarek Mekhail, et al.
The Open Ophthalmology Journal|July 17, 2012
Long-term survivors with metastatic uveal melanomaDominic M Buzzacco, Mohamed H Abdel-Rahman, Stanley Park, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 18, 2011
Gene regulatory and clinical effects of interferon β in patients with metastatic melanoma: a phase II trialErnest C Borden, Barbara Jacobs, Emese Hollovary, et al.
Pageof 7